1. Home
  2. SER vs AAME Comparison

SER vs AAME Comparison

Compare SER & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • AAME
  • Stock Information
  • Founded
  • SER 2017
  • AAME 1968
  • Country
  • SER United States
  • AAME United States
  • Employees
  • SER N/A
  • AAME N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • SER Health Care
  • AAME Finance
  • Exchange
  • SER Nasdaq
  • AAME Nasdaq
  • Market Cap
  • SER 55.2M
  • AAME 56.6M
  • IPO Year
  • SER 2018
  • AAME N/A
  • Fundamental
  • Price
  • SER $5.00
  • AAME $2.83
  • Analyst Decision
  • SER Strong Buy
  • AAME
  • Analyst Count
  • SER 2
  • AAME 0
  • Target Price
  • SER $13.00
  • AAME N/A
  • AVG Volume (30 Days)
  • SER 43.2K
  • AAME 20.4K
  • Earning Date
  • SER 11-11-2025
  • AAME 11-10-2025
  • Dividend Yield
  • SER N/A
  • AAME 0.71%
  • EPS Growth
  • SER N/A
  • AAME N/A
  • EPS
  • SER N/A
  • AAME 0.10
  • Revenue
  • SER $130,000.00
  • AAME $198,977,000.00
  • Revenue This Year
  • SER $134.46
  • AAME N/A
  • Revenue Next Year
  • SER N/A
  • AAME N/A
  • P/E Ratio
  • SER N/A
  • AAME $27.06
  • Revenue Growth
  • SER N/A
  • AAME 6.98
  • 52 Week Low
  • SER $3.81
  • AAME $1.25
  • 52 Week High
  • SER $7.92
  • AAME $3.71
  • Technical
  • Relative Strength Index (RSI)
  • SER 48.12
  • AAME 39.24
  • Support Level
  • SER $4.60
  • AAME $2.81
  • Resistance Level
  • SER $5.01
  • AAME $3.16
  • Average True Range (ATR)
  • SER 0.24
  • AAME 0.13
  • MACD
  • SER -0.02
  • AAME -0.01
  • Stochastic Oscillator
  • SER 57.97
  • AAME 21.30

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: